Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection — PCD Franchise | Trumac Healthcare
Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection
Cytotoxic Chemo — WHO-GMP manufactured, PCD franchise available across India
Form: Injection
Class: Taxane — Breast / Prostate Cancer
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection is a cytotoxic chemotherapy agent used in oncology regimens under specialist supervision. It is available from Trumac Healthcare under WHO-GMP certified manufacturing, with pan-India monopoly PCD franchise opportunity for distributors and stockists.
Therapeutic Indications
- Treatment of selected malignancies as per indication — refer to oncology protocol
- Used as monotherapy or in combination chemotherapy regimens
- May be used in adjuvant, neo-adjuvant or palliative setting depending on tumour type
- Dispensed only against an oncologist's prescription and under specialist supervision
Mechanism of Action
Disrupts tumour cell DNA, RNA or microtubule function — through alkylation, intercalation, antimetabolite incorporation, microtubule binding or platinum-DNA adduct formation — leading to apoptosis of rapidly dividing cancer cells.
Dosage & Administration
- Dosage of Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection must be individualised by the treating physician based on patient age, weight, indication, severity and renal/hepatic function.
- Refer to the official prescribing information for detailed dose, frequency, route and duration.
- Do not exceed the prescribed dose. Complete the full course as advised.
- Adjust dose in renal or hepatic impairment as per prescribing physician.
- Dispense only against a valid prescription from a registered medical practitioner.
Side Effects
- Myelosuppression — neutropenia, thrombocytopenia, anaemia
- Nausea, vomiting
- Mucositis, diarrhoea
- Alopecia
- Increased risk of infection
- Risk of secondary malignancy with long-term cytotoxic exposure
Contraindications
- Severe bone marrow suppression
- Hypersensitivity to the drug
- Severe hepatic / renal impairment without dose adjustment
- Pregnancy and lactation — strictly under specialist guidance
- Active uncontrolled infection
Storage
Store below 30°C in a dry place, protected from light and moisture. Keep in original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
Start Your PCD Franchise for Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Pan-India monopoly territory protection (district / state level)
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Free promotional kit — visual aid, MR bag, sample literature
- ✓ Dispatch within 48 hours on payment realisation
- ✓ Dedicated backend support for billing, dispatch and stock query
Trumac Healthcare supplies Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection with full QC documentation, batch COA and competitive net rates. Packaging is selected for stability during transit across Indian climatic zones. Dispatch within 48 hours of payment realisation, subject to stock availability.
PCD franchise partners receive a free promotional kit (visual aid, sample literature, MR bag), monopoly territory protection, and dedicated backend support for billing and dispatch. Connect with us on WhatsApp at +91 90416 77932 to discuss pricing, packs and your territory.
Frequently Asked Questions
Is Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection available for PCD franchise from Trumac Healthcare?
Yes. Trumac Healthcare offers Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection for pan-India monopoly PCD franchise. We supply WHO-GMP manufactured stock with full QC documentation, batch COA and competitive net rates. Contact us on WhatsApp at +91 90416 77932 for pricing and territory availability.
What is the therapeutic class of Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection?
Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection is a Cytotoxic Chemo — Taxane — Breast / Prostate Cancer.
How quickly can dispatch happen after order confirmation?
For routine PCD orders we dispatch within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain a buffer stock against forecasted monthly off-take.
What documentation do I receive with each order?
Each batch ships with Certificate of Analysis (COA), drug licence copies, GMP certificate and statutory invoice. We support all PCD partner documentation needs including monopoly agreement, rate contract and product list.
Can I get custom packaging or carton sizes?
Yes — custom carton sizes, blister counts and outer designs are available for confirmed monopoly partners subject to minimum order quantity. Please discuss your requirements on WhatsApp.
Do I need a prescription to use this product?
Yes — Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection is a Schedule H / Schedule H1 prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through retail pharmacies and hospital chains only.
Ready to start your PCD franchise for Docetaxel Anhydrous IP 20 mg Polysorbate 80 IP 540 mg Dehydrate Alcohol IP 395 mg 20 mg Injection?